Palo Alto Investors LP Karyopharm Therapeutics Inc. Transaction History

Palo Alto Investors LP

  • $790 Million
  • Q2 2024

A detailed history of Palo Alto Investors LP transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Palo Alto Investors LP holds 5,102,193 shares of KPTI stock, worth $4.34 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
5,102,193
Previous 5,102,193 -0.0%
Holding current value
$4.34 Million
Previous $7.7 Million 42.39%
% of portfolio
0.56%
Previous 0.9%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.68 - $1.31 $390,104 - $751,524
-573,683 Reduced 10.11%
5,102,193 $4.39 Million
Q1 2023

May 15, 2023
BUY
$2.84 - $3.92 $57,368 - $79,184
20,200 Added 0.36%
5,675,876 $22.1 Million
Q4 2022

Feb 14, 2023
BUY
$2.48 - $5.93 $84,674 - $202,467
34,143 Added 0.61%
5,655,676 $19.2 Million
Q1 2022

May 16, 2022
BUY
$5.91 - $14.38 $892,888 - $2.17 Million
151,081 Added 2.76%
5,621,533 $41.4 Million
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $455,354 - $752,514
87,400 Added 1.62%
5,470,452 $35.2 Million
Q2 2021

Aug 16, 2021
BUY
$8.11 - $11.11 $157,334 - $215,534
19,400 Added 0.36%
5,383,052 $55.6 Million
Q1 2021

May 17, 2021
BUY
$9.85 - $17.69 $945,600 - $1.7 Million
96,000 Added 1.82%
5,363,652 $56.4 Million
Q4 2020

Feb 16, 2021
BUY
$14.15 - $17.19 $2.57 Million - $3.12 Million
181,500 Added 3.57%
5,267,652 $81.5 Million
Q3 2020

Nov 16, 2020
BUY
$14.14 - $19.71 $12.3 Million - $17.1 Million
866,700 Added 20.54%
5,086,152 $74.3 Million
Q2 2020

Aug 14, 2020
SELL
$16.6 - $25.25 $1.34 Million - $2.03 Million
-80,449 Reduced 1.87%
4,219,452 $79.9 Million
Q1 2020

May 15, 2020
SELL
$14.38 - $27.72 $4.24 Million - $8.18 Million
-295,100 Reduced 6.42%
4,299,901 $82.6 Million
Q4 2019

Feb 14, 2020
SELL
$9.23 - $19.67 $2.28 Million - $4.86 Million
-247,149 Reduced 5.1%
4,595,001 $88.1 Million
Q3 2019

Nov 14, 2019
SELL
$5.66 - $11.85 $2.38 Million - $4.98 Million
-420,113 Reduced 7.98%
4,842,150 $46.6 Million
Q1 2019

May 15, 2019
BUY
$4.12 - $10.25 $2.38 Million - $5.91 Million
576,911 Added 12.31%
5,262,263 $30.7 Million
Q4 2018

Feb 14, 2019
BUY
$8.2 - $16.95 $180,629 - $373,374
22,028 Added 0.47%
4,685,352 $43.9 Million
Q2 2018

Aug 14, 2018
BUY
$12.0 - $19.88 $11.8 Million - $19.5 Million
983,346 Added 26.72%
4,663,324 $79.2 Million
Q1 2018

May 15, 2018
BUY
$9.92 - $17.25 $1.34 Million - $2.34 Million
135,539 Added 3.82%
3,679,978 $49.4 Million
Q4 2017

Feb 14, 2018
BUY
$9.15 - $11.99 $419,564 - $549,789
45,854 Added 1.31%
3,544,439 $34 Million
Q3 2017

Nov 14, 2017
BUY
$8.15 - $11.16 $28.5 Million - $39 Million
3,498,585
3,498,585 $38.4 Million

Others Institutions Holding KPTI

# of Institutions
115
Shares Held
64.9M
Call Options Held
500K
Put Options Held
99K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67.8M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email